CClinicalTrials.gg
CompletedNCT03997916Updated Jan 19, 2023Results posted

Belun Ring Validation Study for Assessment of Obstructive Sleep Apnea

An interventional study of Belun Ring and PSG in Obstructive Sleep Apnea, sponsored by University Hospitals Cleveland Medical Center. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-19.

Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
113
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to determine the overall accuracy, sensitivity, and specificity of the Belun Ring device in evaluating obstructive sleep apnea by comparing the device to the attended overnight in-lab polysomnography which is the gold standard for diagnosis of obstructive sleep apnea. Our hypothesis is that the Belun-Ring, a type 4 portable monitoring device, is overall sensitive and specific for evaluation of obstructive sleep apnea when compared to the attended overnight in-lab polysomnography.

Read the detailed description

This study will include all patients who are scheduled to do an attended overnight in-lab polysomnography in 2 sleep labs owned by University Hospitals Cleveland Medical Center. These patients will receive email recruitment forms 2 weeks prior their scheduled polysomnography. Whether they are interested or not, patients are supposed to call or email the study's central contact person. Both phone number and email address of the central contact person are noted in the email recruitment form. For those patients who did not make any contact with the study's central contact person, they will be screened for eligibility by sub-investigators through chart review. List of eligible patients will be sent to the central contact backup person who is basically in-charge of making phone calls to the patients. This person will further confirm patients' eligibility over the phone and ask if they are interested. If a patient is interested, the central contact backup person will inform the sub-investigators who, in turn, will assign a unique patient identifier to the interested subject and inform the sleep lab contact person. The sleep lab contact person will, in turn, inform the sleep technicians on-call ahead of time about the list of interested subjects. On the night of the polysomnography testing of the interested subject, the latter will receive questionnaires and written informed consent form related to the study which will be explained by the sleep technician. After the subject had completed and signed the questionnaires and written informed consent form respectively, the sleep technician will apply the Belun Ring device on the patient as well as the electrodes and sensors included in a routine polysomnography. The following day, data from Belun Ring device will be uploaded to the laptop while another sleep technician will read the polysomnography. Sub-investigators will enter the data from the questionnaires, Belun Ring device, and polysomnography in the secured University Hospitals Redcap (UHRedcap). Once the target number of subjects are reached, all data will be sent to statistician for analysis.

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • Belun Ring
  • pulse oximeter
  • obstructive sleep apnea
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

This study's enrollment of 113 is above the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

University Hospitals Cleveland Medical Center is the lead sponsor of 283 studies on the registry; 42 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 29 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All adult patients age 18-80 years old scheduled for overnight in-lab sleep study
  • Provision of signed and dated written informed consent form

Exclusion criteria

Exclusion Criteria:

  • Recent hospitalization in the past 30 days
  • Patients on home oxygen, non-invasive ventilator, diaphragmatic pacing, or any form of nerve stimulator
  • Patients with pacemaker, defibrillator, left ventricular assist device (LVAD), or status post cardiac transplantation
  • Patients with baseline heart rate under 50 bpm or over 100 bpm during last clinic visit or prior to study at the sleep lab
  • Patients with unstable cardiopulmonary status judged to be unsafe for sleep study by the sleep technician and/or the on-call sleep physician in the sleep lab on the night of the study
  • Patients who are unable to complete the required study
  • Patients involved in another investigational study
  • Pregnant women
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
113 participants (actual)

Study arms

  • Other
    Participant

    All patients scheduled for attended overnight in-lab polysomnography (PSG), also known as sleep study, in our 2 sleep labs will undergo PSG testing. On the same night of the PSG testing, these same patients will also wear the Belun Ring device. After the study, we will compare results of the Belun Ring device vis-à-vis with the results of the PSG on the same patient. There will be no separate arm to test a different device.

    Device: Belun Ring · Diagnostic Test: PSG

Interventions

  • DeviceBelun Ring

    All patients scheduled for attended overnight in-lab polysomnography (PSG) in our 2 sleep labs will undergo PSG testing. On the same night of the PSG testing, these same patients will also wear the Belun Ring device. After the study, we will compare results of the Belun Ring device vis-à-vis with the results of the PSG on the same patient.

  • Diagnostic testPSG

    All patients scheduled for attended overnight in-lab polysomnography (PSG) in our 2 sleep labs will undergo PSG testing. On the same night of the PSG testing, these same patients will also wear the Belun Ring device. After the study, we will compare results of the Belun Ring device vis-à-vis with the results of the PSG on the same patient.

06

What researchers measure

Primary outcomes

  1. Performance (Mean With 95% CI) of bAHI at PSG--AHI Cutoffs of 5, 15 and 30 (Accuracy)

    Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

    Time frame: Same night when both testing were done on the same subject

  2. Sensitivity

    Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

    Time frame: Same night when both testing were done on the same subject

  3. Specificity

    Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

    Time frame: Same night when both testing were done on the same subject

07

Results

Posted Jan 19, 2023

Participant flow

Participant flow — Overall Study
MilestoneParticipant
Started113
Completed78
Not completed35
Withdrew: Protocol violation35

Outcome measures

PrimaryPerformance (Mean With 95% CI) of bAHI at PSG--AHI Cutoffs of 5, 15 and 30 (Accuracy)

Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

Time frame:
Same night when both testing were done on the same subject
Reported as:
Number · proportion of events
Performance (Mean With 95% CI) of bAHI at PSG--AHI Cutoffs of 5, 15 and 30 (Accuracy)
proportion of eventsBelun Ring Study Participants
AHI cut off of 50.564 (0.447 to 0.676)
AHI cut off of 150.808 (0.703 to 0.888)
AHI cut off of 300.910 (0.824 to 0.963)
PrimarySensitivity

Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

Time frame:
Same night when both testing were done on the same subject
Reported as:
Number · proportion of events
Sensitivity
proportion of eventsBelun Ring Study Participants
AHI cut off at 51.000 (0.918 to 1.000)
AHI cut off at 150.931 (0.772 to 0.992)
AHI cut off at 300.714 (0.419 to 0.916)
PrimarySpecificity

Comparing the accuracy, sensitivity, specificity of Belun Ring Device versus gold standard Polysomnography for Obstructive Sleep Apnea

Time frame:
Same night when both testing were done on the same subject
Reported as:
Number · proportion of events
Specificity
proportion of eventsBelun Ring Study Participants
AHI cut off of 50.029 (0.001 to 0.149)
AHI cut off of 150.735 (0.589 to 0.850)
AHI cut off of 300.953 (0.869 to 0.990)

Adverse events

Collected over 2 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Belun Ring Device0/78 (0%)0/78 (0%)0/78 (0%)

Baseline characteristics

subjects that are eligible and willing to be consented to participate in the study and whose length of data recording is sufficient for Belun Ring Analysis

Age, Continuous
Age, Continuous(years)Participant
Mean51.5 ± 13.4
Sex: Female, Male
Sex: Female, Male(Participants)Participant
Female51
Male27
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Participant
American Indian or Alaska Native0
Asian30
Native Hawaiian or Other Pacific Islander0
Black or African American41
White4
More than one race0
Unknown or Not Reported3
Body Mass Index (BMI)
Body Mass Index (BMI)(Kg/m^2)Participant
Mean36.1 ± 10.1
STOP-Bang
STOP-Bang(scores on a scale)Participant
Mean3.9 ± 1.8
08

Study locations

2 sites
  • Residence Inn Marriott
    Beachwood, Ohio 44122, United States
  • University Hospitals Cleveland Medical Center
    Cleveland, Ohio 44106, United States
09

References and documents

Publications

  • Yeh E, Wong E, Tsai CW, Gu W, Chen PL, Leung L, Wu IC, Strohl KP, Folz RJ, Yar W, Chiang AA. Detection of obstructive sleep apnea using Belun Sleep Platform wearable with neural network-based algorithm and its combined use with STOP-Bang questionnaire. PLoS One. 2021 Oct 11;16(10):e0258040. doi: 10.1371/journal.pone.0258040. eCollection 2021. Erratum In: PLoS One. 2024 May 9;19(5):e0303713. doi: 10.1371/journal.pone.0303713. PubMed 34634070 ↗

Study documents

  • Protocol and statistical analysis plan · Jul 16, 2019
  • Informed consent form · Jul 16, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03997916
Lead sponsor
University Hospitals Cleveland Medical Center
Collaborators
Belun Technology Company Limited
Responsible party
Eric Yeh, MD (Fellow in Sleep Medicine, University Hospitals Cleveland Medical Center) — Principal investigator
First posted
Jun 25, 2019
Start date
May 6, 2019
Primary completion
Jun 30, 2019
Completion
Jul 30, 2019
Results posted
Jan 19, 2023
Last update
Jan 19, 2023

Study contacts

Eric Yeh, MD
principal investigator · University Hospitals Cleveland Medical Center
Ambrose Chiang, MD
study director · University Hospitals Cleveland Medical Center
Kingman Strohl, MD
study director · University Hospitals Cleveland Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion